NGMD Stock Overview
NuGen Medical Devices Inc., a specialty medical device company, focuses on developing and commercializing novel drug delivery technologies in Europe, Asia, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
NuGen Medical Devices Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.11 |
| 52 Week High | CA$0.26 |
| 52 Week Low | CA$0.09 |
| Beta | 2.73 |
| 1 Month Change | -4.35% |
| 3 Month Change | 15.79% |
| 1 Year Change | -46.34% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -63.93% |
Recent News & Updates
Recent updates
Shareholder Returns
| NGMD | CA Medical Equipment | CA Market | |
|---|---|---|---|
| 7D | -8.3% | -5.6% | -0.6% |
| 1Y | -46.3% | -30.0% | 3.9% |
Return vs Industry: NGMD underperformed the Canadian Medical Equipment industry which returned -30% over the past year.
Return vs Market: NGMD underperformed the Canadian Market which returned 3.9% over the past year.
Price Volatility
| NGMD volatility | |
|---|---|
| NGMD Average Weekly Movement | 11.6% |
| Medical Equipment Industry Average Movement | 11.4% |
| Market Average Movement | 9.1% |
| 10% most volatile stocks in CA Market | 18.3% |
| 10% least volatile stocks in CA Market | 3.1% |
Stable Share Price: NGMD's share price has been volatile over the past 3 months.
Volatility Over Time: NGMD's weekly volatility (12%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Ian Heynen | www.nugenmd.com |
NuGen Medical Devices Inc., a specialty medical device company, focuses on developing and commercializing novel drug delivery technologies in Europe, Asia, and internationally. It offers needle-free injection devices and systems for the administration of subcutaneous medication for various fields, including diabetes, semaglutide, and growth and fertility hormone, as well as DNA and conventional/pediatric vaccines. The company also offers InsuJet system that focus on servicing the diabetic community, as well as V5, V6, and V8 InsuJet injectors and sterile accessories.
NuGen Medical Devices Inc. Fundamentals Summary
| NGMD fundamental statistics | |
|---|---|
| Market cap | CA$23.59m |
| Earnings (TTM) | -CA$8.53m |
| Revenue (TTM) | CA$184.71k |
127.7x
P/S Ratio-2.8x
P/E RatioIs NGMD overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NGMD income statement (TTM) | |
|---|---|
| Revenue | CA$184.71k |
| Cost of Revenue | CA$76.49k |
| Gross Profit | CA$108.22k |
| Other Expenses | CA$8.64m |
| Earnings | -CA$8.53m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.04 |
| Gross Margin | 58.59% |
| Net Profit Margin | -4,620.29% |
| Debt/Equity Ratio | -6,027.1% |
How did NGMD perform over the long term?
See historical performance and comparison